These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18715206)

  • 1. Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting.
    Hermanns N; Kulzer B; Haak T
    Diabetes Technol Ther; 2008 Aug; 10(4):322-7. PubMed ID: 18715206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose accuracy of SoloSTAR and FlexPen as assessed in a clinical setting.
    Friedrichs A
    Diabetes Technol Ther; 2009 Sep; 11(9):609-13. PubMed ID: 19764841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels.
    Penfornis A; Horvat K
    Diabetes Technol Ther; 2008 Oct; 10(5):359-62. PubMed ID: 18715211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the SoloSTAR insulin pen.
    Schwartz S; Vlajnic A
    Diabetes Technol Ther; 2008 Oct; 10(5):351-7. PubMed ID: 18715210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose accuracy and injection force dynamics of a novel disposable insulin pen.
    Clarke A; Spollett G
    Expert Opin Drug Deliv; 2007 Mar; 4(2):165-74. PubMed ID: 17335413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pan-European and Canadian prospective survey to evaluate patient satisfaction with the SoloSTAR insulin injection device in type 1 and type 2 diabetes.
    Hancu N; Czupryniak L; Genestin E; Sourij H
    J Diabetes Sci Technol; 2011 Sep; 5(5):1224-34. PubMed ID: 22027323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T; Edelman S; Walter C; Lecointre B; Spollett G
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals.
    Pfützner A; Forst T; Niemeyer M; Bailey T
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1381-9. PubMed ID: 24921223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy and Injection Force of the Gla-300 Injection Device Compared With Other Commercialized Disposable Insulin Pens.
    Klonoff D; Nayberg I; Thonius M; See F; Abdel-Tawab M; Erbstein F; Haak T
    J Diabetes Sci Technol; 2015 Aug; 10(1):125-30. PubMed ID: 26311720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Insulin Underdelivery from Prefilled and Reusable Insulin Pens in Cases of Premature Needle Withdrawal: A Laboratory Evaluation.
    Joubert M; Haddouche A; Morera J; Rod A; Reznik Y
    Diabetes Technol Ther; 2015 Oct; 17(10):712-6. PubMed ID: 26355757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing Accuracy of Two Disposable Insulin Pens According to New ISO 11608-1: 2012 Requirements.
    Abdel-Tawab M; Schmitz M; Kamlot S; Schubert-Zsilavecz M
    J Diabetes Sci Technol; 2015 Jul; 10(1):157-61. PubMed ID: 26187635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the dosing accuracy of commonly used disposable insulin pens.
    Krzywon M; van der Burg T; Fuhr U; Schubert-Zsilavecz M; Abdel-Tawab M
    Diabetes Technol Ther; 2012 Sep; 14(9):804-9. PubMed ID: 22694223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usability, participant acceptance, and safety of a prefilled insulin injection device in a 3-month observational survey in everyday clinical practice in Australia.
    Carter J; Beilin J; Morton A; De Luise M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1425-38. PubMed ID: 20144398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Evaluation of the Reusable JuniorSTAR® Half-Unit Insulin Pen.
    Klonoff D; Nayberg I; Rabbone I; Domenger C; Stauder U; Oualali H; Danne T
    J Diabetes Sci Technol; 2015 May; 9(3):625-31. PubMed ID: 25633967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.
    Brunton S
    Diabetes Technol Ther; 2008 Aug; 10(4):247-56. PubMed ID: 18715198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection force of SoloSTAR® compared with other disposable insulin pen devices at constant volume flow rates.
    van der Burg T
    J Diabetes Sci Technol; 2011 Jan; 5(1):150-5. PubMed ID: 21303637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus.
    Xie L; Zhou S; Wei W; Gill J; Pan C; Baser O
    Diabetes Technol Ther; 2013 Mar; 15(3):230-6. PubMed ID: 23336845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing accuracy and insulin flow rate characteristics of a new disposable insulin pen, FlexTouch, compared with SoloSTAR.
    Bohnet J; Schmitz M; Kamlot S; Abdel-Tawab M
    J Diabetes Sci Technol; 2013 Jul; 7(4):1021-6. PubMed ID: 23911185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the dose accuracy of prefilled insulin pens.
    Weise A; Pfützner JW; Borig J; Pfützner AM; Safinowski M; Hänel H; Musholt PB; Pfützner A
    J Diabetes Sci Technol; 2009 Jan; 3(1):149-53. PubMed ID: 20046658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.